Use this report's 28 commercial variables to build your own, customized data sets for cancer drug launches. 

By combining spending and staffing data from the report's 28 different brand types, you can build resource benchmarks to fit your own unique challenges. 

The report's data sets are divided into 10 chapters:

• Chapter 1: Drug Class – Explores resources for cytotoxics and innovative therapies
   
• Chapter 2: Market Entrance – Explores resources for first-to-market brands and follow-on/me-too brands
   
• Chapter 3: Indications – Explores resources for brands indicated to treat leukemia, breast cancer, lung cancer, prostate cancer and colorectal cancer
   
• Chapter 4: Peak Sales – Explores resources for brands with projected peak annual sales of more than $1 billion, $500 million to $999 million, and less than $500 million
   
• Chapter 5: Line of Treatment – Explores resources for first-line, second-line and third-line therapeutics
   
• Chapter 6: Clinical Profile – Explores resources for brands with favorable, average, and unfavorable clinical profiles
   
• Chapter 7: Industry Sector – Explores resources for brands commercially supported by major pharmaceutical companies and by biotechnology companies
   
• Chapter 8: Competitive Landscape – Explores resources for brands with strong, average and weak competitive positions
   
• Chapter 9: Promotional Infrastructure – Explores resources for brands with access to strong, average and weak internal resources
   
• Chapter 10: Drug Delivery – Explores resources for brands delivered orally and intravenously

For more information on what is contained in this report and how it can be of value to you and your team, please call Oveda Slade at +1 919-403-6583 or e-mail info@cuttingedgeinfo.com.

 

More Cutting Edge Information Reports: